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Abstract
Background Most questionnaires currently used for assessing symptomatology of vestibular disorders are retrospective, 
inducing recall bias and lowering ecological validity. An app-based diary, administered multiple times in daily life, could 
increase the accuracy and ecological validity of symptom measurement. The objective of this study was to introduce a new 
experience sampling method (ESM) based vestibular diary app (DizzyQuest), evaluate response rates, and to provide exam-
ples of DizzyQuest outcome measures which can be used in future research.
Methods Sixty-three patients diagnosed with a vestibular disorder were included. The DizzyQuest consisted of four ques-
tionnaires. The morning- and evening-questionnaires were administered once each day, the within-day-questionnaire 10 
times a day using a semi-random time schedule, and the attack questionnaire could be completed after the occurrence of a 
vertigo or dizziness attack. Data were collected for 4 weeks. Response rates and loss-to-follow-up were determined. Reported 
symptoms in the within-day-questionnaire were compared within and between patients and subgroups of patients with dif-
ferent vestibular disorders.
Results Fifty-one patients completed the study period. Average response rates were significantly higher than the desired 
response rate of > 50% (p < 0.001). The attack-questionnaire was used 159 times. A variety of neuro-otological symptoms and 
different disease profiles were demonstrated between patients and subgroups of patients with different vestibular disorders.
Conclusion The DizzyQuest is able to capture vestibular symptoms within their psychosocial context in daily life, with lit-
tle recall bias and high ecological validity. The DizzyQuest reached the desired response rates and showed different disease 
profiles between subgroups of patients with different vestibular disorders. This is the first time ESM was used to assess daily 
symptoms and quality of life in vestibular disorders, showing that it might be a useful tool in this population.
Keywords DizzyQuest · Experience sampling · Vestibular disorders
Introduction
Dizziness, imbalance and vertigo are common complaints, 
with a prevalence of up to 36% in the outpatient population 
[1]. A subset of these complaints is caused by vestibular dis-
orders [2]. These vestibular disorders can present with dif-
ferent clinical pictures, varying from acute attacks of vertigo 
to chronic complaints [3–5]. Patients with a vestibular dis-
order can also suffer from other problems like depression, 
increased risk of falling and cognitive impairment, with 
many socio-economic consequences [6]. To evaluate the 
symptoms and consequences of vestibular disorders, ques-
tionnaires like the Dizziness Handicap Inventory (DHI) [7], 
the Hospital Anxiety and Depression Scale (HADS) [8], the 
Short-Form Health Survey (SF-36) [9], Short Falls Efficacy 
Scale-International (Short FES-I) [10], and the EQ-5D-5L 
are often used.
However, there are two main drawbacks tied to the use 
of cross-sectional instruments. First, most of these ques-
tionnaires are retrospective, and require recollection and 
adequate aggregation. This imposes a high risk of recall 
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bias, since some variables might be overestimated or 
underestimated. Secondly, most of these questionnaires 
only yield one observation and miss documenting vari-
ability in symptomatology or risk patterns in the context 
of daily life. Cross-sectional instruments are not able to 
capture dynamic components (e.g., fluctuating symptoms) 
and the influence of context (e.g., environmental or psy-
chological factors, etc.), which are relevant indicators for 
symptom management. Understanding symptoms in the 
normal flow of daily life improves the ecological validity: 
it better reflects the real life response of symptoms to real 
life challenges [11–13]. Especially in vestibular disorders 
which can have a very fluctuating clinical presentation 
with vertigo attacks, questionnaires prone to recall bias 
and lower ecological validity, are suboptimal to study the 
exact frequency of attacks, their possible triggers and the 
quality of life in vestibular disorders.
In the past, the Experience Sampling Method (ESM) was 
developed to overcome recall bias and to increase the eco-
logical validity of measurements of health outcomes. His-
torically, paper and pencil procedures were burdensome. 
Recently, apps on a smartphone improved data collection 
logistics. In ESM the information about an individuals’ 
current state and functioning, as well as circumstances and 
context, is documented by self-report in real-time using a 
random time sampling procedure to repeatedly fill in ques-
tionnaires for a longer period of time. The questionnaires 
have to be filled out multiple times a day, at most 10 times. 
On these moments, a notification beep alerts the subject 
to fill out an assessment form. A questionnaire can also be 
filled out by the subject in case of a certain trigger or event 
[11]. ESM not only reduces the risk of recall bias, it also 
makes it possible to obtain information about the variability 
of attacks over time [13]. Furthermore, the existence and 
influence of environmental, social and psychological fac-
tors can be investigated at the same time [14]. Momentary 
assessment has already been successfully used in studies on 
other diseases, e.g., tinnitus [15], psychological disorders 
[16–18] and Parkinson’s disease [19]. However, there is only 
scarce evidence in vestibular disorders, using techniques that 
to a certain extent resemble ESM [14].
Since patients often bring their own (non-standardized) 
“vestibular diary” to the clinic and currently many new 
therapeutic strategies are being investigated [20–40], stand-
ardized monitoring of patients using ESM improves clini-
cal work and research, complementary to existing question-
naires. Therefore, the Dizzynet network [41, 42] developed 
a new app-based diary for vestibular disorders: the Dizzy-
Quest. Main objective of this study was to describe the first 
version of the DizzyQuest, to evaluate response rates, and to 
provide examples of DizzyQuest outcome measures which 
can be used in future research, like the variability of neuro-
otological symptoms over time using the ESM method, and 




Patients with various vestibular disorders were recruited at 
the vestibular department of Maastricht University Medi-
cal Center, Apeldoorn Dizziness Center, Haga Hospital and 
the ‘Hoormij’ foundation, all in the Netherlands. Inclusion 
criteria comprised: (1) age 18 years or older; (2) diagnosed 
with a vestibular disorder by an otorhinolaryngologist with 
an expertise in vestibular disorders, according to the Barany 
Society diagnostic criteria [43–46] (if applicable); (3) good 
understanding of the Dutch language (reading and listening); 
(4) in possession of a smartphone or tablet; (5) being capable 
to install and use the DizzyQuest (see below for explanation 
of the application). Patients were excluded if they did not 
feel comfortable to answer questions from the DizzyQuest, 
for example, concerning their psychological status.
The DizzyQuest
The DizzyQuest is an app-based electronic diary that is 
implemented on the “UM ESM” (v2.04) platform. This is 
an experimental version of the PsyMate™ app (http://www.
psyma te.eu) used for research at Maastricht University. The 
app allows implementation of ESM based protocols with 
multiple questionnaires and sampling schemes [47]. It is 
available as a download for smartphones running on iOS 
and Android. The DizzyQuest consists of four question-
naires. The “within-day-questionnaire” assesses the current 
situation at semi-random intervals throughout the day in the 
tradition of the ESM method for 10 times a day. The other 
three questionnaires are retrospective, in principle reflect-
ing an aggregated situation of the previous night (morning 
questionnaire), or previous day (evening questionnaire). The 
attack questionnaire is event based and filled in after the 
occurrence of an attack of vertigo or dizziness (Table 1). It 
can be completed at any time after an attack, even after more 
than 1 day (Online Resource 1). Each questionnaire has its 
own specific set of questions, although considerable overlap 
exists between some of them (e.g. the within-day-question-
naire and the evening-questionnaire, see Online Resource 1 
for the translated version). All four questionnaires combined, 
not only measure vestibular symptoms, but also emotion, 
cognition, context and stressful events. All questions about 
symptoms use the seven-point Likert scale, ranging from 1 
(not at all) to 7 (very). It should be noted that the question-
naires were provided in Dutch. In this language, “dizziness” 
and “vertigo” are often used interchangeably in contrast to 
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the English language, in which “dizziness” and “vertigo” are 
considered two different entities [48].
These different strategies (momentary versus retrospec-
tive) and different questionnaires, provide the opportunity 
to measure multiple aspects of neuro-otological symptoms 
and their psychosocial context. Table 2 provides possible 
outcome measures that can be obtained by the DizzyQuest 
on an individual level.
Study design
Before start of the DizzyQuest study, patients were con-
tacted by two of the authors (SvdW, AE) and instructed on 
how to use the app. An online video was used for instructing 
the patients how to use the DizzyQuest (Online Resource 
2). After that, the DizzyQuest was used for four sequen-
tial weeks. In this study, not all questionnaires were applied 
in the same frequency and for the same duration (Table 1). 
In the first week, each day contained one morning-ques-
tionnaire, 10 within-day-questionnaires and one evening-
questionnaire. Subjects received the within-day-question-
naires 10 times a day, between 07:30 a.m. and 22:30 p.m., 
at semi-random moments (a day consisted of ten 90-min 
blocks and at a random moment in each block, a question-
naire was sent to the patient). The morning-, day- and even-
ing-questionnaires were activated at 04:00 a.m. and 07:30 
p.m. respectively, with a reminder on the smartphone or 
tablet at 9:00 a.m. and 8:00 p.m. respectively. They could 
be answered for a period of 8 and 8.5 h, respectively. The 
within-day-questionnaires were activated after a signalling 
beep/notification on the device. The subject was able to fill 
in the questionnaire within a time window of 15 min. When 
the opportunity to fill in the questionnaire closed, the ques-
tionnaires disappeared from the home screen and data were 
archived as “negative response”. The attack-questionnaire 
could be used at any given moment, as many times a day 
as needed. Subjects were instructed on the first day and 
debriefed on day 28. After the first week, only the even-
ing- and attack-questionnaires remained. Therefore, in the 
last 3 weeks, patients only had to fill in one questionnaire a 
day (the evening-questionnaire), and optionally the attack-
questionnaire in case of an attack of vertigo or dizziness, to 
reduce the burden for subjects.
Patient monitoring
The ESM UM Reporting Tool provides the opportunity for 
online monitoring of results. It was used to remotely monitor 
compliance of patients by two of the authors (SvdW, AE). 
In case a patient did not start the DizzyQuest at the prede-
termined day, or when sequentially multiple questionnaires 
were not answered, patients were contacted by phone or 
e-mail to provide any help if necessary (e.g., technical help).
Data analysis
Patients that started in the first week and continued the use 
of the DizzyQuest up to and including the fourth week, 
were included in the analysis. No minimum threshold of 
response rates was required. DizzyQuest data were extracted 
from the ESM UM database and transferred to IBM SPSS 
Statistics Version 25 (IBM Corporation, New York, United 
States of America). Data from the first day (briefing) was 
incomplete and skipped from the analysis, leaving only 
within-day-questionnaire data from day two until seven. 
The morning questionnaire was available from day two until 
eight, resulting in 7 days of data to be used for analysis. 
The evening- and attack-questionnaires were available for 
the whole 28 days period. Descriptive statistics were used. 
Furthermore, a Mann–Whitney U test, Fisher’s Exact test 
Table 1  Questionnaires used in the DizzyQuest
Questionnaire Focus Nature Frequency in this study
Morning (7 questions) Quality of sleep past night Retrospective Daily in first week
Within-day (23 questions) Real-time symptoms in daily life 
context
Momentary (= ESM) Ten times a day at semi-random 
moments in the first week
Evening (27 questions) Symptoms of the past day Retrospective Daily during 4 weeks
Attack (5 questions) Symptoms of attack Retrospective After an attack of vertigo or dizziness
Table 2  Possible outcome measures of the DizzyQuest (on individual 
level)
Outcome measure Facilitating 
question-
naire
Behaviour of symptoms during the day Within-day
Behaviour of symptoms between days Morning
Within-day
Evening





Frequency and nature of attack of vertigo or dizziness Attack
Evening
 Journal of Neurology
1 3
and a Fisher-Freeman-Halton exact test of independence 
were used to calculate differences in age, gender and diag-
nosis respectively, between the study group and drop-out 
group. The average response rate of each patient for each 
questionnaire was calculated by dividing the amount of fully 
completed questionnaires by the number of scheduled ques-
tionnaires. Only fully completed questionnaires were consid-
ered as valid. It was hypothesized that not all administered 
questionnaires would be completed. A desired response rate 
of > 50% was used, since reported response rates in current 
literature about momentary assessments are often higher 
than 50% [49, 50]. To calculate whether response rates of 
the DizzyQuest questionnaires were significantly different 
from the > 50% desired response rate [47, 51], a one-sample 
T test was performed.
Regarding presence of neuro-otological symptoms, 
they were considered “reported” and present, when they 
were selected in the question: ‘Now I suffer from’ (Online 
Resource 1). The reported frequency (%) of neuro-otologi-
cal symptoms obtained with the within-day questionnaire, 
was first calculated for each symptom per patient. This was 
done by dividing the amount of times a specific symptom 
was reported, by the amount of times the individual patient 
completed the within-day questionnaire. This resulted in a 
patient-specific percentage. This patient-specific percentage 
was used to determine the mean reported frequency (%) of 
all patients, divided in three subgroups of vestibular disor-
ders: Menière’s disease (MD), bilateral vestibulopathy (BV), 
and other vestibular disorders.
Marginal logistic regression analysis based on the gener-
alized estimated equations analysis (GEE) method for binary 
outcomes was used to test significant differences in reported 
symptoms between subgroups of vestibular disorders and 
the outcomes were Bonferroni corrected. An exchange-
able covariance structure was applied, since time interval 
between within-day questionnaires was not constant.
To investigate the effect of neuro-otological symptoms 
on questions regarding positive affect and negative affect, 
linear mixed-effects regression analysis was performed. 
The independent variables in the models were one of the 
neuro-otological symptoms (“imbalance”, “tinnitus” and 
“visual problems when moving”). The score on one of the 
questions regarding positive affect (“I generally feel well 
at the moment”) and negative affect (“I’m worrying about 
things”) was the dependent variable. In case of a significant 
interaction was found between the diagnosis group and the 
neuro-otological symptom, the analysis was performed for 
each diagnosis group separately.
To investigate differences between the three subgroups 
regarding amount of completed attack-questionnaires, the 
mean number of completed attack-questionnaires was first 
calculated per day for each patient by [amount of attack 
questionnaires completed by a specific patient/28 days]. 
Subsequently, a Kruskal–Wallis test was used to test for 
systematic differences between the three groups. In case of 
a significant Kruskal–Wallis test, post hoc analyses included 
three pairwise Bonferroni corrected Mann–Whitney U tests. 
For all performed statistic tests, p-values below 0.05 were 
considered statistically significant.
Ethical considerations
This study was in accordance with the legislation and ethical 
standards on human experimentation in the Netherlands and 
in accordance with the Declaration of Helsinki (amended 
version 2013). The medical ethical committee of Maas-
tricht UMC+ approved this study (2018-0809) and written 




Sixty-three patients were included in this study. Twelve 
patients dropped out of the study for a variety of rea-
sons (e.g., technical problems or personal circumstances) 
as described in Table  3. Fifty-one patients completed 
the 4-week study period. This group consisted mostly of 
females (n = 33) and had a mean age of 56 years old (range 
27–80  years). Etiologies comprised Menière’s disease 
(n = 19), vestibular migraine (n = 3), vestibulopathy (n = 1 
unilateral, n = 23 bilateral) and overlap syndrome between 
Menière’s disease and vestibular migraine (n = 5). There 
were no significant differences between the patients who 
completed the study period and the patients who dropped 
out, regarding age (p = 0.475), gender (p = 0.309) and ves-
tibular diagnosis (p = 0.367).
Response rates
Figure 1 presents the average response rates of fully com-
pleted questionnaires of the DizzyQuest. The response rates 
were 90% for the morning-questionnaire, 62% for the within-
day-questionnaire and 87% for the evening-questionnaire. 
The response rates of the morning, day and evening ques-
tionnaires were significantly different from the desired a pri-
ori defined response rate of > 50% (p < 0.001) respectively.
Examples of outcome measures of the DizzyQuest 
on an individual level
The DizzyQuest enables the opportunity to give addi-
tional insights in fluctuation of symptoms during a spe-
cific time period (e.g., day or week), and to investigate 
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the appearance of symptoms in relation to psychosocial 
context (Table 2). Figure 2a, b present examples of the 
association of imbalance and general well-being during 
a day (Fig. 2a) and a month (Fig. 2b) in a patient with 
Menière’s disease, as a representative sample of results 
obtained in this study. Figure 3 presents the average scores 
of all 10 administered within-day-questionnaires during 
six consecutive days regarding imbalance and general 
well-being in the same patient. These figures show that 
with the DizzyQuest, it is possible to calculate correlations 
between the appearance of symptoms and their context, 
on an individual and group level (see below “Appearance 
of neuro-otological symptoms in relation to psychosocial 
context”). 
Table 3  Characteristics of patients who dropped out during this study
VM vestibular migraine, PPPD persistent postural perceptual dizziness, MD Menière’s disease, UVP unilateral vestibulopathy, DFNA9 genetic 
type of cochleovestibular dysfunction, leading to deafness and bilateral vestibulopathy
Patient 
number
Diagnosis Gender Age (years) Reason for drop-out
1 VM/PPPD Female 63 Prioritized treatment for another medical disorder
2 MD Female 43 Could not combine the application with work
3 MD Female 37 Changed her mind regarding participation after inclusion in study
4 BV Female 44 Prioritized treatment for another medical disorder
5 PPPD Female 51 Technical problems: did not receive evening questionnaires after using another device
6 MD Female 59 Technical problems: incorrect login
7 MD Female 52 Technical problems: incorrect login
8 MD Male 59 Frequency of within-day questionnaires was too high to combine participation in this 
study with personal life
9 DFNA9 Male 70 Technical problems: dissatisfied about the application
10 MD Female 64 Personal circumstances
11 UVP Female 61 Technical problems: application did not work properly
12 MD Female 44 Death of family member
Fig. 1  The average response rates of fully completed questionnaires 
of the DizzyQuest. Error bars indicate 95% confidence intervals of 
average response rates of all participants on the specific question-
naire. The black horizontal bar indicates the desired response rate 
of > 50%. Asterisks indicate a statistically significant difference in 
response rate from the desired > 50% response rate
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Examples of outcome measures of the DizzyQuest 
on group level
Frequency of reported symptoms 
in the within‑day‑questionnaire (ESM method)
In total, 51 patients reported 5829 neuro-otological symp-
toms in the within-day-questionnaire. Figure 4 demonstrates 
the mean reported frequency (%) of neuro-otological symp-
toms, obtained with the within-day questionnaire, during 
six consecutive days in 51 patients. These are graphically 
displayed in three subgroups by diagnosis: Menière’s dis-
ease (n = 19), bilateral vestibulopathy (n = 23), and other 
vestibular disorders (n = 9). Mostly reported symptoms 
were tinnitus and imbalance, while light flashes were least 
reported. Furthermore, variability can be observed between 
type of symptoms and subgroups of vestibular disorders. 
Patients with bilateral vestibulopathy reported imbalance 
significantly more often than patients with Menière’s disease 
(p = 0.003, OR = 5.279, 95% CI 1.917; 14.533) and patients 
with other vestibular diagnoses (p = 0.012, OR = 0.142, 
95% CI 0.037; 0.540). Patients with bilateral vestibulopa-
thy reported also significantly more often visual problems 
when moving compared to patients with Menière’s disease 
(p = 0.033, OR = 7.735, 95% CI 1.595; 37.524) and patients 
with other vestibular diagnoses (p < 0.001, OR = 0.038, 95% 
CI 0.012; 0.126).
Appearance of neuro‑otological symptoms in relation 
to psychosocial context
The appearance of three neuro-otological symptoms (imbal-
ance, tinnitus and visual problems while moving), and their 
association with questions about positive affect (“I generally 
feel well at the moment”) and negative affect (“I’m worry-
ing about things”) is presented in Table 4. Linear mixed-
model regression analysis showed that the appearance of 
imbalance, tinnitus and visual problems while moving, were 
nearly always significantly associated with a decrease in “I 
generally feel well at the moment” for all subgroups of ves-
tibular disorders (except visual problems when moving in 
patients with Menière’s disease). Regarding the question 
Fig. 2  a, b Examples of DizzyQuest results of a patient with 
Menière’s disease regarding imbalance (red) and general well-being 
(blue) during one specific day and 1  month, as a representative 
sample of results obtained in this study. Likert scores on the y-axes 
vary from 1 (not at all) to 7 (very). a Illustrates the results of the 10 
within-day-questionnaires that were administered on day five of the 
study. b Illustrates the results of the evening questionnaires obtained 
during 28 consecutive days
Fig. 3  a, b Average daily scores of imbalance (red, a) and general 
well-being (blue, b) obtained with the within-day-questionnaires that 
were administered 10 times a day during six consecutive days, in 
the same patient with Menière’s disease. Dots represent the average 
scores of all completed within-day-questionnaires during a specific 
day. Error-bars show the 95% confidence intervals
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“I’m worrying about things”, the presence of imbalance was 
associated with a lower score.
Frequency and nature of attacks of vertigo or dizziness
The attack-questionnaire was used 159 times to indicate 
an attack of vertigo or dizziness. The median of number 
of reported vertigo attacks in the attack questionnaire per 
day was 0.071 for patients with Menière’s disease, 0.036 
for patients with bilateral vestibulopathy and 0.143 for 
patients with other vestibular disorders. Patients in the sub-
group “other vestibular disorders” reported significantly 
more often a vertigo attack than patients in the subgroup 
“bilateral vestibulopathy” (p = 0.033).
On an individual level, it was observed that the attack- 
and evening-questionnaires showed different results 
regarding the reported frequency and nature (e.g., triggers, 
duration) of attacks of vertigo or dizziness. This inter-
esting finding was outside the scope of this article, since 
it mainly results from the differences between reporting 
strategies: event sampling (attack-questionnaire) and time 
sampling (evening-questionnaire). This will therefore be 
discussed separately [52].
Fig. 4  Mean reported frequency (%) of neuro-otological symptoms, 
obtained with the within-day questionnaire, during six consecutive 
days in 51 patients, divided in three subgroups of vestibular disorders. 
Asterisks above a subgroup bar indicate a statistically significant dif-
ference in reported frequency of a symptom in that specific subgroup, 
compared to the other two
Table 4  Results of the mixed-
effects linear regression 
analyses regarding the 
appearance of three neuro-
otological symptoms and two 
questions about positive affect 
and negative affect, calculated 
for three subgroups of vestibular 
disorders
BV bilateral vestibulopathy, MD Menière’s disease
*p < 0.05
a Applicable to all subgroups
Symptoms Questions regarding positive affect and negative affect
I generally feel well at the moment I’m worrying about things
Estimate 95% CI p-value Estimate 95% CI p-value
Lower Upper Lower Upper
Imbalance = no − 0.466a − 0.697 − 0.234 < 0.001* 0.193a 0.044 0.341 0.014*




BV: − 0.234 − 0.440 0.029 0.025* 0.12a − 0.046 0.290 0.156
Other: − 1.163 − 1.877 − 0.450 0.001*
MD: − 0.147 − 0.624 0.331 0.547
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Discussion
The objective of this study was to introduce the first ver-
sion of the DizzyQuest, to evaluate its response rates, and 
to provide examples of DizzyQuest outcome measures 
which can be used in future research. Response rates to 
all investigated questionnaires of the DizzyQuest were sig-
nificantly higher than the desired response rate of > 50%. 
The DizzyQuest is able to capture a variety of symptoms, 
including significant variability of symptomatology within 
and between participants and between subgroups of vestib-
ular disorders. Furthermore, it was demonstrated that the 
Dizzyquest facilitates investigation of significant relations 
between symptoms and their psychosocial context. This is 
the first time that ESM has been used to assess symptoms 
in a population with vestibular disorders.
Main advantage of the DizzyQuest is the fact that it 
dynamically captures symptoms and their psychosocial 
context, by administering questionnaires multiple times 
to the same patient during patients’ daily life. Therefore, 
it allows specific insights in the course of symptoms over 
time, and how they correlate with psychosocial factors. 
The DizzyQuest measures “in the moment” (within-day-
questionnaire) or with limited retrospection (morning-, 
evening- and attack-questionnaire), herewith decreasing 
recall bias and improving reliability. Since it is used in 
daily life, the ecological validity might be improved com-
pared to many currently available questionnaires which 
are administered once a week at most. These aspects will 
likely be very valuable when investigating the effect of 
therapies for vestibular disorders, especially in cases of 
fluctuating symptoms like in Menière’s disease [40, 53]. 
In the future, it could open doors to ecological momentary 
interventions, which take place in real time and in real 
world [54]. The repetitive measurement of the DizzyQuest 
also provides much larger numbers of data about the same 
topics, in and between patients. This allows for higher sta-
tistical accuracy in a smaller number of patients, and pro-
vides the opportunity of patients serving as their own con-
trol condition during intervention studies (e.g., n = 1 study 
[55]). Moreover, symptom occurrence and worsening can 
be understood, since ESM allows the study of the mutual 
interaction of symptoms. Taking these considerations into 
account, the DizzyQuest could be used as a (complemen-
tary) tool for investigating symptoms and quality of life in 
patients with vestibular disorders.
Average response rates of the morning-questionnaire 
were the highest, while those of the within-day-ques-
tionnaire were the lowest. Additionally, the drop-out rate 
was 19% of patients. Fortunately, no patients dropped out 
due to any experienced psychological burden related to 
DizzyQuest use. Mostly reported reasons for drop-out 
involved technical problems and personal circumstances 
(e.g., combining the DizzyQuest with daily life activities). 
Regarding technical problems, these might be addressed 
by more strict monitoring of the patients in future trials, 
and to provide technical help if necessary. However, per-
sonal circumstances as a reason for drop-out, imply that 
responding to random signals is demanding in a practi-
cal way. Subjects have only 15 min to respond. Espe-
cially the within-day-questionnaire could be perceived 
as a burden, according to patients’ feedback. After all, 
the within-day-questionnaire was administered 10 times 
a day in the first week. By providing questions 10 times a 
day, it was aimed to reach at least five completed within-
day-questionnaires per day. Therefore, a lower response 
rate was expected compared to the morning and evening 
DizzyQuest questionnaires. Although the desired response 
rate was reached, the average response rate on the within-
day-questionnaire in the patients that completed the whole 
study period, was slightly lower than in similar research 
across different domains [56, 57]. It is therefore strongly 
advised, especially when using the demanding within-day-
questionnaire, to provide patients with proper guidance 
during the study period. This might increase adherence 
[58]. Another complementary strategy would be to lower 
the within-day-questionnaire frequency, however, at the 
risk of getting too little data.
A variety of symptoms was reported within and between 
patients. It should be noted that these symptoms reflect the 
study population, and not the patients with vestibular disor-
ders in general. For example, tinnitus was the most reported 
symptom, probably reflecting the overrepresentation of 
Menière’s disease patients in this study population. Nev-
ertheless, it has been shown that the DizzyQuest captured 
different profiles of symptomatology between subgroups 
of vestibular disorders. For example, imbalance and visual 
problems while moving (referring to oscillopsia) were sig-
nificantly more reported in patients with bilateral vestibu-
lopathy. These findings were expected, since they (partially) 
reflect the diagnostic criteria established for this disorder 
[46]. In addition, patients with bilateral vestibulopathy 
reported on average the lowest amount of vertigo attacks. 
Taking these results into account, it can be concluded that 
the DizzyQuest is able to measure different profiles of 
symptomatology between patients with different vestibular 
disorders.
Furthermore, the DizzyQuest facilitated the investigation 
of the relationship between neuro-otological symptoms and 
their psychosocial context. It was demonstrated that psycho-
social well-being can be significantly negatively influenced 
by neuro-otological symptoms like imbalance, tinnitus and 
oscillopsia. This is congruent with previous literature in 
which it was shown that patients with vertigo or dizziness 
are more prone to have psychiatric co-morbidity and in these 
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cases more often report depression, anxiety and vertigo-
related handicap [59]. The DizzyQuest might therefore be 
used as a complementary tool to further explore the interface 
between neuro-otological symptoms and their psychosocial 
context in future research.
Limitations
A subset of the study population was loss-to-follow-up. This 
implies that results are only a reflection of the patients that 
completed the whole 4-week study period. Whether this 
has induced any selection bias, cannot be ruled out. Fur-
thermore, completing the questionnaires might take some 
time, especially in the beginning. However, bothersome time 
consumption was not measured in this study. After famil-
iarization with the questionnaires, time to complete each 
questionnaire dropped to on average 2 min, according to the 
patients’ feedback.
In this first article about the DizzyQuest, it would have 
been preferred to also report on its content and construct 
validity. However, since the development of the DizzyQuest 
was a very long and thorough process according to the COS-
MIN guidelines [60], it was decided to report this separately 
in an article fully devoted to the validity of the DizzyQuest 
(manuscript in preparation).
Future steps to DizzyQuest
To fully capture symptoms of patients and their psycho-
social context, focus groups were recently conducted, in 
which the questionnaires were discussed in a standardized 
way [56, 61]. Patients and doctors got the opportunity to 
include, exclude and rephrase questionnaire items. These 
results will be implemented in the updated version of the 
DizzyQuest. Furthermore, the DizzyQuest should also be 
validated, including comparison to currently used question-
naires like the DHI and HADS (concurrent validity), and it 
should be translated into multiple languages. Preliminary 
observations showed in some cases discrepancies between 
reported symptoms in the within-day-questionnaire and the 
evening-questionnaire (data not shown). This is probably 
due to the different nature of the questionnaires (momentary 
versus retrospective design) and their timing (multiple times 
a day versus only one time during the evening).
Moreover, recent technological innovations resulted in 
portable hearing tests [62], video-oculography goggles 
for home use [63] and wearable movement sensors [64]. 
Simultaneous data-acquisition of these devices in combina-
tion with the DizzyQuest during daily life, might result in 
clinically useful insights regarding the correlation between 
subjective symptoms and objective measurements in patients 
with vestibular disorders. Finally, it should be noted that the 
frequency of administering the DizzyQuest questionnaires is 
not fixed. For example, in this study the within-day-question-
naire was administered 10 times a day for 1 week. However, 
this could be changed to e.g., 6 times a day for 2 weeks. 
Currently, two versions of the DizzyQuest are being devel-
oped for use in the near future: an updated extensive ver-
sion for research including all questionnaires mentioned in 
this study, and a short DizzyQuest including only the even-
ing- and attack-questionnaire. This latter should be able to 
serve as a standardized vestibular diary with relatively little 
retrospectivity, but without the burden of the within-day-
questionnaire. However, it should be noted that not using 
momentary assessments might decrease the sensitivity and 
the ability to investigate symptom appearance in relation to 
psychosocial context [65].
Conclusion
The DizzyQuest is able to capture vestibular symptoms 
within their psychosocial context in daily life, with little 
recall bias and high ecological validity. The DizzyQuest 
reached the desired response rates and showed different 
disease profiles between subgroups of patients with dif-
ferent vestibular disorders. This is the first time ESM was 
used to assess daily symptoms and quality of life in vestibu-
lar disorders, showing that it might be a useful tool in this 
population.
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